**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 111-83-1 |1-Bromooctane | 97.0 | 203-912-9 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: None Listed.
Risk Phrases: None Listed.
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Not available.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. Low hazard for usual industrial handling.
Ingestion:
Low hazard for usual industrial handling.
Inhalation:
Low hazard for usual industrial handling.
Chronic:
No information found.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Flush skin with plenty of water for at least 15 minutes while
removing contaminated clothing and shoes. Get medical aid if
irritation develops or persists.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical
aid.
Inhalation:
Remove from exposure and move to fresh air immediately. Get medical
aid if cough or other symptoms appear.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. Use water
spray to keep fire-exposed containers cool. Combustible liquid.
Extinguishing Media:
In case of fire, use water, dry chemical, chemical foam, or
alcohol-resistant foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth),
then place in suitable container. Clean up spills immediately,
observing precautions in the Protective Equipment section.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Use with adequate ventilation. Avoid
contact with eyes, skin, and clothing. Keep container tightly closed.
Keep away from heat, sparks and flame. Avoid ingestion and
inhalation. Do not pressurize, cut, weld, braze, solder, drill,
grind, or expose empty containers to heat, sparks or open flames.
Storage:
Keep away from heat, sparks, and flame. Keep away from sources of
ignition. Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Always use
a NIOSH or European Standard EN 149 approved
respirator when necessary.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Liquid
Color: colorless
Odor: none reported
pH: Not available.
Vapor Pressure: 0.41 mm Hg @20C
Viscosity: Not available.
Boiling Point: 203 deg C
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: 77 deg C ( 170.60 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: Negligible.
Specific Gravity/Density: 1.1200g/cm3
Molecular Formula: C8H17Br
Molecular Weight: 193.13
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, strong oxidants.
Incompatibilities with Other Materials:
Strong oxidizing agents - strong bases.
Hazardous Decomposition Products:
Carbon monoxide, carbon dioxide, hydrogen bromide.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 111-83-1: RG8575000
LD50/LC50:
CAS# 111-83-1: Oral, rat: LD50 = 4490 uL/kg; Skin, rabbit: LD50 = 8
mL/kg.
Carcinogenicity:
1-Bromooctane -
Not listed by ACGIH, IARC, or NTP.
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 111-83-1: 1
United Kingdom Occupational Exposure Limits
United Kingdom Maximum Exposure Limits
Canada
CAS# 111-83-1 is listed on Canada's DSL List.
CAS# 111-83-1 is not listed on Canada's Ingredient Disclosure List.
Exposure Limits
US FEDERAL
TSCA
CAS# 111-83-1 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 8/24/1997 Revision #2 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
1,1',3,3,3',3'-Hexamethyl-4,4',5,5'-dibenzo-2,2'-indotricarbocyanine
| 23178-67-8 |
|
1-Bromooctane, 97% (gc)
| 111-83-1 |
|
n-Octyl 4-chloroacetoacetate, tech. 85%
| 41051-21-2 |
|
Magnesium Hydroxide
| 1309-42-8 |
|
5-Nitrosalicylic Acid, 99%
| 96-97-9 |
|
Quinaldine red, 99% (uv-vis)
| 117-92-0 |
|
Silver nitrite, 99%
| 7783-99-5 |
|
Magnesium nitrate hexahydrate
| 10377-60-3 |
|
2,4-Dichloronitrobenzene, 97%
| 611-06-3 |
|
Magnesium Oxide
| 1309-48-4 |
|
Magnesium Perchlorate Anhydrous
| 10034-81-8 |
|
Pyrrole, 99%
| 109-97-7 |
|
Dextro,levo-10-camphorsulfonic acid, sodium salt, 98%
| 34850-66-3 |
|
2-Amino-4,6-Dihydroxy-5-Methylpyrimidine 99%
| 55477-35-3 |
|
N-Carbobenzyloxy-L-Valine, 99+%
| 1149-26-4 |
|
Calcium bromide dihydrate, 99+%
| 7789-41-5 |
|
Phenyl Acridine-9-Carboxylate
| 109392-90-7 |
|
(R,R)-(-)-2,3-Dimethoxy-1,4-Bis(Dimethylamino)Butane, 96%
| 26549-22-4 |
|
Magnesium sulfate anhydrous
| 7487-88-9 |
|
Guanidine carbonate, 97% (titr.)
| 593-85-1 |
|
4-Ethoxy-3-Methoxybenzaldehyde, 95%
| 120-25-2 |
|
Magnesium sulfate heptahydrate
| 7487-88-9 |
|
3-(N-Benzyl-N-methylamino)-1,2-propanediol 96+%
| 60278-98-0 |
|
Maleic acid
| 110-16-7 |
|
Malonic acid
| 141-82-2 |
|
Oil for Heat Transfer
| 0-01-1 |
|
D-(+)-Maltose Monohydrate
| 69-79-4 |
|
Manganese(II) chloride tetrahydrate
| 7773-01-5 |
|
2-Aminobenzimidazole, 95% (titr.)
| 934-32-7 |
|
Manganese (IV) Dioxide
| 1313-13-9 |
|
Cesium Fluoride, 99%
| 13400-13-0 |
|
2,2'-Dipyridylamine, 99%
| 1202-34-2 |
|
Manganese (II) Nitrate Solution
| 7697-37-2 |
|
Methylglyoxal bis-(guanyl-hydrazone) dihydrochloride monohydrate,
| 24968-67-0 |
|
N-Methyl-D-Glucamine, 99%
| 6284-40-8 |
|
1,5-Dibromopentane, 97%
| 111-24-0 |
|
Manganese(II) sulfate monohydrate
| 7785-87-7 |
|
Pentachloropyridine, 98%
| 2176-62-7 |
|
Mannitol
| 69-65-8 |
|
N,N-Dimethyl-O-Phenylenediamine Dihydrochloride, 99% (Titr.)
| 62654-07-3 |
|
Trimethyltin chloride, 99%
| 1066-45-1 |
|
Salicylamide, 99%
| 65-45-2 |
|
5-alpha-Cholestane, 98+%
| 481-21-0 |
|
2-Methyl-5-nitroimidazole, 99%
| 88054-22-2 |
|
2-Mercaptoethanol
| 60-24-2 |
|
Mercury(II) acetate
| 1600-27-7 |
|
Cytidine-2'(3')-Monophosphoric Acid, 99+%
| 84-52-6 |
|
Cis-2-Hydroxy-1-Cyclopentanecarboxamide 99+%
| 40481-98-9 |
|
Fast Blue B Salt
| 14263-94-6 |
|
M-Nitrocinnamic Acid, 99%, Predominantly Trans
| 555-68-0 |
|
|